11-65014233-A-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001667.4(ARL2):āc.26A>Gā(p.Lys9Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000413 in 1,574,698 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001667.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARL2 | NM_001667.4 | c.26A>G | p.Lys9Arg | missense_variant | Exon 1 of 5 | ENST00000246747.9 | NP_001658.2 | |
ARL2 | NM_001199745.2 | c.26A>G | p.Lys9Arg | missense_variant | Exon 1 of 4 | NP_001186674.1 | ||
ARL2-SNX15 | NR_037650.2 | n.74A>G | non_coding_transcript_exon_variant | Exon 1 of 11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARL2 | ENST00000246747.9 | c.26A>G | p.Lys9Arg | missense_variant | Exon 1 of 5 | 1 | NM_001667.4 | ENSP00000246747.4 | ||
ARL2-SNX15 | ENST00000301886.3 | n.26A>G | non_coding_transcript_exon_variant | Exon 1 of 11 | 2 | ENSP00000476630.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000293 AC: 6AN: 204674Hom.: 0 AF XY: 0.0000354 AC XY: 4AN XY: 112992
GnomAD4 exome AF: 0.0000436 AC: 62AN: 1422536Hom.: 0 Cov.: 30 AF XY: 0.0000368 AC XY: 26AN XY: 707210
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152162Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.26A>G (p.K9R) alteration is located in exon 1 (coding exon 1) of the ARL2 gene. This alteration results from a A to G substitution at nucleotide position 26, causing the lysine (K) at amino acid position 9 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at